Increasing evidence suggests the oncogenic function of overexpressed CKS2 in various human cancers, including adrenocortical carcinoma, tongue squamous cell carcinoma, lung adenocarcinoma, and hepatocellular carcinoma [13–16]. This evidence concerns the gene CKS2 and cancer.